Work

Cortisol exposure and sensitivity in health and disease

Year: 2013
Type: dissertation
Abstract: Cortisol, the main glucocorticoid (GC) in man, is produced by the adrenal glands \nand its secretion is under control of the Hypothalamic-Pituitary-Adrenal (HPA) \naxis. Activation of the HPA-axis begins with the release of corticotrophinreleasing \nhormone (CRH) from neurons in the paraventricular nucleus (PVN) of \nthe hypothalamus (1). CRH is released in the hypophysial-portal circulation and \nbinds to the type 1 corticotrophin releasing hormone receptors (CRH-R1) on the \nanterior pituitary corticotroph cells. This stimulates the biosynthesis and secretion \nof adrenocorticotropic hormone (ACTH) (2). This hormone is produced by cleavage \nof pro-opiomelanocortin (POMC). ACTH is released in the peripheral circulation \nand stimulates glucocorticoid production by the zona fasciculate cells of the adrenal \ncortex, by binding to the type 2 melanocortin receptor (MC2-R). Binding of ACTH \nto its receptor results in elevated intracellular levels of cyclic AMP (cAMP), which \nultimately leads to activation of steroidogenic enzymes, which are required for the \ncortisol synthesis from cholesterol (3-4). There are three regulatory mechanisms of \ncortisol secretion, namely 1) the inhibition of ACTH and CRH production by cortisol \nitself (negative feedback), 2) the circadian rhythm of ACTH and cortisol secretion \nand 3) the response to stress of the HPA-axis. A simplified version of the HPA-axis \nis shown in figure 1.
Language: English
Open Access status: green
OpenAlex ID: W2118068490
Cites: 271
Cited by:
Related to: 10